Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)
Clinical trial NCT02383810 · COMPLETED
Trial details
- NCT number
- NCT02383810
- Sponsor
- Helsinn Healthcare SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-02-01
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.